[1]
N. Geada, I. Mafra, R. Barroso, and J. Franco, “Atypical Femoral Fractures and Bisphosphonates Treatment: Is it a Risk Factor?”, Acta Med Port, vol. 27, no. 6, pp. 704–709, Dec. 2014.